Literature DB >> 16936639

The retinoid X receptor ligand restores defective signalling by the vitamin D receptor.

Ruth Sánchez-Martínez1, Ana I Castillo, Andreas Steinmeyer, Ana Aranda.   

Abstract

It is assumed that the retinoid X receptor (RXR) acts as a silent partner to the vitamin D receptor (VDR) with its only function to increase affinity of VDR/RXR to its DNA recognition site. In this study, we show that the RXR ligand 9-cis-retinoic acid (9-cis-RA) induces recruitment of coactivators by the DNA-bound heterodimer and potentiates vitamin D-dependent transcriptional responses. The presence of 9-cis-RA increases induction of cyp24 transcripts and differentiation of colon cancer cells by vitamin D, confers significant agonistic activity to a VDR ligand with very low agonistic activity and can even restore transcriptional activity of an AF-2 mutant VDR that causes hereditary rickets. This study shows that, in VDR/RXR heterodimers, allosteric communication triggered by the RXR ligand has a previously unrecognized role in vitamin D signalling, with important physiological and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936639      PMCID: PMC1618365          DOI: 10.1038/sj.embor.7400776

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  14 in total

Review 1.  Nuclear hormone receptors and gene expression.

Authors:  A Aranda; A Pascual
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

2.  Structural determinants of allosteric ligand activation in RXR heterodimers.

Authors:  Andrew I Shulman; Christopher Larson; David J Mangelsdorf; Rama Ranganathan
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

3.  Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.

Authors:  Pierre Germain; Jaya Iyer; Christina Zechel; Hinrich Gronemeyer
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

4.  A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.

Authors:  Peter J Malloy; Rong Xu; Lihong Peng; Pamela A Clark; David Feldman
Journal:  Mol Endocrinol       Date:  2002-11

5.  Antagonistic action of a 25-carboxylic ester analogue of 1alpha, 25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators.

Authors:  M Herdick; A Steinmeyer; C Carlberg
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

6.  Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor.

Authors:  Eiji Ochiai; Daishiro Miura; Hiroshi Eguchi; Sachiko Ohara; Kazuya Takenouchi; Yoshiaki Azuma; Takashi Kamimura; Anthony W Norman; Seiichi Ishizuka
Journal:  Mol Endocrinol       Date:  2005-01-13

7.  Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.

Authors:  Giuseppe Tocchini-Valentini; Natacha Rochel; Jean-Marie Wurtz; Dino Moras
Journal:  J Med Chem       Date:  2004-04-08       Impact factor: 7.446

8.  Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.

Authors:  David J Bettoun; Thomas P Burris; Keith A Houck; Donald W Buck; Keith R Stayrook; Berket Khalifa; Jianfen Lu; William W Chin; Sunil Nagpal
Journal:  Mol Endocrinol       Date:  2003-07-31

9.  Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.

Authors:  Janeen L Vanhooke; Matthew M Benning; Cary B Bauer; J Wesley Pike; Hector F DeLuca
Journal:  Biochemistry       Date:  2004-04-13       Impact factor: 3.162

10.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

Authors:  H G Pálmer; J M González-Sancho; J Espada; M T Berciano; I Puig; J Baulida; M Quintanilla; A Cano; A G de Herreros; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  14 in total

1.  A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.

Authors:  Bentley J Hanish; Jennifer F Hackney Price; Ichiro Kaneko; Ning Ma; Arjan van der Vaart; Carl E Wagner; Peter W Jurutka; Pamela A Marshall
Journal:  Steroids       Date:  2018-04-26       Impact factor: 2.668

Review 2.  A review of the molecular design and biological activities of RXR agonists.

Authors:  Nathalia Rodrigues de Almeida; Martin Conda-Sheridan
Journal:  Med Res Rev       Date:  2019-04-03       Impact factor: 12.944

Review 3.  Vitamin D resistance and colon cancer prevention.

Authors:  Charles Giardina; James P Madigan; Cassandra A Godman Tierney; Bruce M Brenner; Daniel W Rosenberg
Journal:  Carcinogenesis       Date:  2011-12-16       Impact factor: 4.944

4.  Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.

Authors:  Jan B Egan; Patricia A Thompson; Erin L Ashbeck; David V Conti; David Duggan; Elizabeth Hibler; Peter W Jurutka; Elizabeth C Leroy; María Elena Martínez; David Mount; Elizabeth T Jacobs
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

5.  Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers.

Authors:  Ruth Sánchez-Martínez; Alberto Zambrano; Ana I Castillo; Ana Aranda
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

6.  Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation.

Authors:  Loretta L Hoover; Elizabeth G Burton; Megan L O'Neill; Bonnie A Brooks; Shilpa Sreedharan; Nineveh A Dawson; Steven W Kubalak
Journal:  Biochim Biophys Acta       Date:  2008-08-13

7.  Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers.

Authors:  Ting-Yuan David Cheng; Gary E Goodman; Mark D Thornquist; Matt J Barnett; Shirley A A Beresford; Andrea Z LaCroix; Yingye Zheng; Marian L Neuhouser
Journal:  Int J Cancer       Date:  2014-03-24       Impact factor: 7.396

Review 8.  Inhibitors for the Vitamin D Receptor-Coregulator Interaction.

Authors:  Kelly A Teske; Olivia Yu; Leggy A Arnold
Journal:  Vitam Horm       Date:  2015-11-30       Impact factor: 3.421

9.  Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages.

Authors:  Inés Pineda Torra; Naima Ismaili; Jonathan E Feig; Chong-Feng Xu; Claudio Cavasotto; Raluca Pancratov; Inez Rogatsky; Thomas A Neubert; Edward A Fisher; Michael J Garabedian
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

10.  Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells.

Authors:  Lajos Széles; Szilárd Póliska; Gergely Nagy; Istvan Szatmari; Attila Szanto; Attila Pap; Malin Lindstedt; Saskia J A M Santegoets; Ralph Rühl; Balázs Dezsö; László Nagy
Journal:  Mol Endocrinol       Date:  2010-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.